NDC 11673-283 - Daytime Nighttime Sinus Relief
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11673-283
- Manufacturer
- Target Corporation | LNK International, Inc.
- Effective date
- 2026-05-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Target 44-615694-09 Delisted | Target Corporation | LNK International, Inc. | 2026-05-18 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen | ACETAMINOPHEN | RAONBIO CORP | f6f5251d-db89-4b69-e053-6394a90a1028 | 2025-12-19 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | WALGREENS | 8f8d43d1-8e73-483e-e053-2a95a90ac99b | 2025-12-19 | Warnings | 362O9ITL9D |
| DayTime Cold/Flu Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | ARMY AND AIR FORCE EXCHANGE SERVICE | 04f9134e-1311-4843-90db-9244b9e61e1d | 2025-12-19 | Warnings | 04JA59TNSJ 362O9ITL9D |
| Nighttime Cold/Flu Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | ARMY AND AIR FORCE EXCHANGE SERVICE | 029e6215-b72d-4fd0-8918-db1abcc4490a | 2025-12-19 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | PUBLIX SUPERMARKETS, INC | 08f57305-0c4b-96b1-e063-6394a90a77df | 2025-12-19 | Warnings | 362O9ITL9D |
| Acetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | LEADER/ Cardinal Health 110, Inc. | f1d69088-4d52-cbb5-e053-2995a90a3ec8 | 2025-12-19 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | WALGREENS CO. | 8dba6ae0-1bfb-84de-e053-2a95a90aae46 | 2025-12-19 | Warnings | 362O9ITL9D |
| Acetaminophen and Diphenhydramine HCL | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | PUBLIX SUPERMARKETS, INC | 08f549cf-042a-7bf2-e063-6394a90a83ef | 2025-12-19 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | LEADER/ Cardinal Health 110, Inc | f797848e-f23f-997b-e053-6394a90aae55 | 2025-12-19 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | MAJOR PHARMACEUTICALS | efd0a432-abbb-1f88-e053-2995a90a8ce5 | 2025-12-19 | Warnings | 362O9ITL9D |
| Childrens Allergy Relief | DIPHENHYDRAMINE HCL | Marc Glassman, Inc. | e916ef86-ca73-42dd-83dc-6033f56d96f2 | 2025-12-19 | Warnings | TC2D6JAD40 |
| Acetaminophen | ACETAMINOPHEN | WALGREEN CO. | b8a855ae-c0a3-0b05-e053-2a95a90ac8a8 | 2025-12-19 | Warnings | 362O9ITL9D |
| Acetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | RUGBY LABORATORIES | ed340993-04e6-b084-e053-2a95a90abf60 | 2025-12-19 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | LEADER/ Cardinal Health 110, Inc | f5dc335d-d3cf-ba94-e053-2a95a90ac6d3 | 2025-12-19 | Warnings | 362O9ITL9D |
| Guaifenesin | GUAIFENESIN | TARGET CORPORATION | 09957814-61e2-4488-e063-6294a90a2201 | 2025-12-19 | Warnings | 495W7451VQ |
| Childrens Pain and Fever | ACETAMINOPHEN | Marc Glassman, Inc. | f708e1ec-cf2a-4e2b-851f-f6b703f359b2 | 2025-12-19 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | WALGREEN CO. | b375de90-25c7-aa55-e053-2995a90a3cf8 | 2025-12-19 | Warnings | 362O9ITL9D |
| Guaifenesin | GUAIFENESIN | TARGET CORPORATION | 0a0aa190-8dc7-f9cc-e063-6394a90a6078 | 2025-12-19 | Warnings | 495W7451VQ |
| Acetaminophen | ACETAMINOPHEN | TARGET CORPORATION | e64a3c32-5466-0662-e053-2a95a90ae963 | 2025-12-19 | Warnings | 362O9ITL9D |
| Naproxen Sodium and Diphenhydramine HCL | NAPROXEN SODIUM AND DIPHENHYDRAMINE HCL | TARGET CORPORATION | fe82699d-fdc2-038e-e053-6294a90a606c | 2025-12-19 | Warnings | TC2D6JAD40 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.